Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family

Inclusion Criteria: * Standard indication for de novo, upgrade or replacement pacemaker or cardiac resynchronization therapy pacemaker (CRT-P) implantation * Ability to understand the nature of the study * Willingness to provide written informed consent * Ability and willingness to perform all follow-up visits at the study site * Ability and willingness to use the CardioMessenger and acceptance of the BIOTRONIK Home Monitoring® concept Exclusion Criteria: * Planned for conduction system pacing * Planned cardiac surgical procedures or interventional measures other than the study procedure within the next 12 months * Known pregnancy or breast feeding * Age less than 18 years * Participation in another interventional clinical investigation * Life-expectancy less than 12 months